Teledyne Labtech and Bangor University Pioneer Welsh Space Cooling Project Teledyne Labtech, a global leader in advanced electronic printed circuit board (PCB) solutions, is spearheading an ambitious Welsh-led initiative that could transform the way spacecraft manage heat in the unforgiving…
Pi Health, a global health technology and clinical research company, today announced a strategic collaboration with GSK to deliver fully outsourced clinical research services. The partnership aims to meaningfully improve the speed and efficiency of the clinical trial process. Under…
Drug Farm, a private biotechnology company pioneering the use of genetics and artificial intelligence to discover and develop innovative immune-modulating therapies, announced today that it has entered into a Material Transfer Agreement (MTA) with Cincinnati Children’s Hospital Medical Center (CCHMC).…
Bayer announced significant progress today in its efforts to develop new treatment options for Parkinson’s disease (PD), a chronic and progressive neurodegenerative disorder that affects millions of people worldwide. The company reported two important clinical trial milestones: the initiation of…
NucleoBio, Corp., a biotechnology innovator in precision oncology diagnostics, has announced a new strategic collaboration with PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory. The partnership will support the clinical development and processing of Prostac™, NucleoBio’s proprietary diagnostic…
Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis Apollo Therapeutics, a leading portfolio biopharmaceutical company, announced today positive topline results from its Phase 2a CHAMELEON trial evaluating camoteskimab, an investigational anti-IL-18 monoclonal antibody, in patients with…
Areteia Reports Positive Phase III Results for Oral Dexpramipexole in Eosinophilic Asthma Areteia Therapeutics, Inc. announced today that its Phase III EXHALE-4 clinical trial has met key efficacy and safety endpoints for dexpramipexole, an investigational oral therapy being developed as…
Ionis Pharmaceuticals, Inc. marked a major milestone today, celebrating the 10th anniversary of Surf Away+, its signature adaptive community event. What began as an initiative to provide people with spinal muscular atrophy (SMA) access to adaptive surfing has evolved into…
ISG (Information Services Group), a global AI-focused technology research and advisory firm, has announced the winners of the third annual ISG Women in Digital Awards for the Asia Pacific region. The program, launched in the Americas in 2022 and expanded…
Vertex Scientists Honored with Prestigious Lasker~DeBakey Award for Transformational Advances in Cystic Fibrosis Vertex Pharmaceuticals Incorporated announced today that Dr. Paul Negulescu, Senior Vice President, has been named a recipient of the 2025 Lasker~DeBakey Clinical Medical Research Award. Dr. Negulescu…
Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company pioneering innovative cancer therapeutics, announced today it will host a virtual Key Opinion Leader (KOL) event on Thursday, September 18 at 5:00 p.m. ET / 2:00 p.m. PT. The event will spotlight interim…
Ferring Pharmaceuticals Co., Ltd. announced today that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has formally accepted the New Drug Application (NDA) for nadofaragene firadenovec, a novel non-replicating intravesical gene therapy developed for patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle…